GVHD-like erythroderma in the clinical course of thymoma-associated myasthenia gravis
暂无分享,去创建一个
Shigeaki Suzuki | N. Suzuki | M. Amagai | J. Nakahara | M. Kohno | T. Funakoshi | H. Nomura | Satoshi Yamada | F. Yasuda-Sekiguchi
[1] H. Shimizu,et al. Cutaneous Manifestations of Thymoma-associated Multi-organ Autoimmunity: A Fatal Sign. , 2016, Acta dermato-venereologica.
[2] H. Nakagawa,et al. Thymoma-associated cutaneous graft-versus-host-like disease possibly treated with narrow-band UVB phototherapy , 2016, European Journal of Dermatology.
[3] Nils Erik Gilhus,et al. Myasthenia gravis: subgroup classification and therapeutic strategies , 2015, The Lancet Neurology.
[4] A. Marx,et al. Thymoma related myasthenia gravis in humans and potential animal models , 2015, Experimental Neurology.
[5] Shigeaki Suzuki,et al. Overlooked non-motor symptoms in myasthenia gravis , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[6] M. Okumura,et al. Diminished regulatory T cells in cutaneous lesions of thymoma‐associated multi‐organ autoimmunity: a newly described paraneoplastic autoimmune disorder with fatal clinical course , 2011, Clinical and experimental immunology.
[7] H. Nagai,et al. Chemotherapy improves thymoma-associated graft-versus-host-disease-like erythroderma , 2011, BMJ Case Reports.
[8] N. Mitsiades,et al. Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like disease. , 2007, Journal of the American Academy of Dermatology.
[9] D. Bostwick,et al. CASE REPORT: Graft-Versus-Host-Like Colitis and Malignant Thymoma , 2002, Digestive Diseases and Sciences.
[10] K. Nehal,et al. Graft-versus-host disease-like erythroderma: a manifestation of thymoma-associated multiorgan autoimmunity. , 2015, Journal of cutaneous pathology.